Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company is headquartered in Raleigh, North Carolina.
52W High
$2.07
52W Low
$1.17
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.65
Valuation
Attractive
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
6.94
EV/EBITDA (<8 favorable)
5.29
EV/Revenue (<3 favorable)
1.77
P/S (TTM) (<3 favorable)
0.36
P/B (<3 favorable)
0.73
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
26.13%
Institutions (25–75% balanced)
4.62%
Shares Outstanding
54,513,000
Float
27,296,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
238,845,000
Gross Profit (TTM)
42,051,000
EPS (TTM)
-0.44
Profit Margin (>10% good)
-0.28%
Operating Margin (TTM) (higher better)
-0.87%
ROE (TTM) (>15% strong)
-0.17%
EPS YoY (Quarterly) (>10% good)
-0.85
Revenue YoY (Quarterly) (>8% good)
-0.23
Momentum
Bearish momentumValue
-0.0028
Previous
-0.0001
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025